Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09YAL
|
||||
Former ID |
DNC007225
|
||||
Drug Name |
6-tert-Butyl-2-morpholin-4-yl-4H-thiopyran-4-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528738] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H19NO2S
|
||||
Canonical SMILES |
CC(C)(C)C1=CC(=O)C=C(S1)N2CCOCC2
|
||||
InChI |
1S/C13H19NO2S/c1-13(2,3)11-8-10(15)9-12(17-11)14-4-6-16-7-5-14/h8-9H,4-7H2,1-3H3
|
||||
InChIKey |
HCEFXOMYHGQVRM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA-dependent protein kinase catalytic subunit | Target Info | Inhibitor | [528738] | |
KEGG Pathway | Non-homologous end-joining | ||||
Cell cycle | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
Reactome | Nonhomologous End-Joining (NHEJ) | ||||
References | |||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. | ||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.